Mountain View, CA – Cordance Medical, a pioneer in non-invasive medical technologies for brain disease treatment, is pleased to announce that its founder and CEO, Bhaskar Ramamurthy, has been invited to participate in a panel discussion at the prestigious Precision Medicine World Conference (PMWC) 2025. The conference will take place from February 5–7 in Santa Clara, California.
The panel, part of Track 1: Cell & Gene Therapies in Oncology, is titled “Advancements and Future Directions in Therapeutic Ultrasound for Precision Medicine,” and will be held on the afternoon of February 6. Bhaskar will be joined by esteemed experts Masha Stromme (Vice Chair of the Board of Directors, EXACT Therapeutics), Dr. John de Groot (Professor and Division Chief of Neuro-Oncology, UCSF), and Dr. Raag Airan (Assistant Professor, Radiology, Stanford) to discuss the latest breakthroughs and potential of therapeutic ultrasound in transforming precision medicine.
“PMWC provides an unparalleled platform to share and discuss cutting-edge advancements,” said Bhaskar Ramamurthy. “I look forward to engaging with fellow panelists and attendees on the future of therapeutic ultrasound and its critical role in shaping accessible and effective treatments for brain diseases.”
For more information about PMWC 2025 and the panel discussion, visit PMWC Website.
About Cordance Medical
Cordance Medical specializes in innovative, non-invasive solutions for treating brain diseases. The company’s flagship NeuroAccess™ platform is designed to enable precise, targeted treatment options, improving patient outcomes worldwide.